CanniMed

Description

CanniMed^® Ltd. was established in 2013 to provide Canadian patients with access to a standardized and trusted supply of pharmaceutical-grade cannabis under the Marihuana for Medical Purposes Regulations (MMPR) governed by Health Canada.

Our history is much deeper, however. Our parent company, Prairie Plant Systems, was the sole supplier to Health Canada under the previous MMAR program, and as a result of these 14 years, we have implemented standard procedures and processes that are in line with pharmaceutical manufacturing standards to ensure consistency of our products for Canadian patients.

Our Vision

Our vision at CanniMed^® Ltd. is to help people with chronic and terminal illnesses improve their quality of life when conventional medicine just isn’t enough. We focus on producing pharmaceutical-grade cannabis through research and development as well as through collaborations with external partners, including academic institutions and healthcare professionals.

Safety

Patient safety is paramount at CanniMed^® Ltd.

Our pharmaceutical-grade cannabis products are grown in accordance with rigorous health and safety standards and produced under Good Manufacturing Practices (GMP) helping to ensure a safe and reliable product. GMP is the criteria used to manufacture all pharmaceuticals in Canada.

Contact us

1 Plant Technology Road
Box 19A, RR#5
Saskatoon, SK.
Canada, S7K 3J8

Website: Cannimed.ca